We’ll continue hydroxychloroquine clinical trials for the treatment of Coronavirus in Nigeria – NAFDAC

The National Agency for Food and Drug Administration and Control says it will continue hydroxychloroquine clinical trials for the treatment of COVID – 19 in Nigeria despite the suspension of the same by the World Health Organisation .

NAFDAC Director- General , Prof Mojisola Adeyeye , made this known on Tuesday during a programme on Television Continental.

Adeyeye said there are proven records that hydroxychloroquine had been effective in the treatment of COVID – 19 patients , especially those at the “mild stage” of the virus .

“ There is data to prove that hydroxychloroquine worked for many COVID – 19 patients .

Therefore , we would continue our own clinical trials in Nigeria .


Hydroxychloroquine has been proved to work at a mild stage.

So the potency depends on the severity of the disease in the patient’ s body, ” she said .

The NAFDAC DG , who said Lagos State had already begun hydroxychloroquine clinical trials , noted that depending on the speed of work , the clinical trials should conclude in three to four months .

“ If medical doctors , research scientists, pharmacists , herbal experts work together , we should conclude the clinical trial in three to four months .

The narrative might change afterwards but for now , we believe in hydroxychloroquine. ”

Reports that the United Nations specialised agency on global health said on Monday that it had “ temporarily ” suspended the clinical trials of hydroxychloroquine as a potential treatment for COVID – 19.

It said the decision followed a study that using the drug on COVID – 19 patients could increase their chance of dying .

“ The Executive Group has implemented a temporary pause of the hydroxychloroquine arm within the Solidarity Trial while the safety data is reviewed by the Data Safety Monitoring Board , ” said WHO Chief , Tedros Ghebreyesus.

He stressed that hydroxychloroquine and chloroquine “ are accepted as generally safe for use in patients with autoimmune diseases or malaria ”, noting that the suspension was a temporary measure .

Share your story with us:sms-+2348107564051, WhatsApp – +2348055459181 – Email – loudspeaker4naija@gmail.com

Remember:Enter your email address to subscribe to this blog and receive notifications of new posts by email. Advertise with us. Send us enquiries , press release.
Subscribe Now/share/comments/Liked

You can also visit our YouTube channel/YouTube.com/LOUDSPEAKER4NAIJA TV


152 thoughts on “We’ll continue hydroxychloroquine clinical trials for the treatment of Coronavirus in Nigeria – NAFDAC

Leave a Reply

Your email address will not be published. Required fields are marked *

Loudspeaker4naija Entertainments